FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to novel substituted derivatives of cyclohexan-1,4-diamine of the general formula (I): possessing binding property with ORLI receptors and showing homology to opioid μ-, κ- and δ-receptors. Compounds can be used for preparing drugs possessing analgesic effect. In the formula (I) R1 and R2 mean independently of one another (C1-C8)-alkyl, or residues R1 and R2 form in common a ring and mean -CH2-CH2NR6CH2CH2 or -(CH2)3-6 wherein R means (C1-C8)-alkyl; R3 means phenyl, naphthyl or 5-membered sulfur-containing heteroaryl wherein each of them is unsubstituted or monosubstituted with halogen atom, or unsubstituted phenyl added through saturated unsubstituted (C1-C4)-alkyl group; R4 means hydrogen atom (H), saturated (C1-C8)-alkyl or -C(X)R7 wherein X means oxygen (O) or sulfur (S) atom; R means H or (C1-C8)-alkyl either unsubstituted phenyl or phenyl substituted with halogen atom; R5 means (C3-C8)-cycloalkyl, adamantyl, aryl or 5-membered heteroaryl comprising 1-3 heteroatoms chosen from nitrogen, oxygen or sulfur and condensed with one or two benzene rings and wherein each of them is unsubstituted or monosubstituted with a substitute chosen from halogen atom, lower alkyl, lower alkoxy, hydroxy or benzyloxy; or -CHR11R12, -CHR11-CH2R12, -CHR11-CH2-CH2R12, -CHR11-CH2-CH2-CH2R12, -C(Y)R12 wherein Y means O or H2; R11 means H, saturated, linear or branched (C1-C7)-alkyl, saturated or unsaturated, linear or branched, mono- or multisubstituted either unsubstituted -C(O)O-(C1-C6)-alkyl; R12 means phenyl or 5-membered heteroaryl comprising 1-3 heteroatoms chosen from nitrogen, oxygen or sulfur condensed with one or two benzene rings each of them is unsubstituted or mono- or multisubstituted and wherein in values R11 and R12 substituted of alkyl, phenyl or heteroaryl are chosen from halogen atom, lower alkyl, lower alkoxy, hydroxy, trifluoromethyl or benzyloxy; or R4 and R5 form in common 5-membered nitrogen-containing heterocycle that represents unsaturated, monosubstituted lower alkoxycarbonyl-lower alkyl, halogen atom, or it is unsubstituted and condensed with benzene ring under condition that if R means substituted or unsubstituted phenyl and at least one R1 or R2 means (C1-C8)-alkyl then R4 can't mean alkyl, and R3 and R5 can't form in common heterocycle, or if R3 means unsubstituted phenyl and R1 and R2 mean in common -(CH2)5 then R4 means H or (C1-C8)-alkyl; Y means O, and R5 doesn't mean (C1-C6)-alkyl. Also, invention relates to a method for synthesis of compounds of the formula (I) and a drug.
EFFECT: valuable medicinal properties of compounds.
40 cl, 1 tbl, 94 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED DERIVATIVES OF 2-PYRIDINCYCLOHEXANE-1,4-DIAMINE, METHOD FOR THEIR PREPARING AND MEDICINAL AGENT BASED ON THEREOF | 2002 |
|
RU2287523C2 |
SPIROCYCLIC CYCLOHEXANE DERIVATIVES | 2003 |
|
RU2354656C2 |
SUBSTITUTED CYCLOHEXYLDIAMINES | 2009 |
|
RU2526251C2 |
SUBSTITUTED DERIVATIVES OF 4-AMINOCYCLOHEXANOL, METHOD FOR THEIR PREPARING AND THEIR USING, MEDICINAL AGENT POSSESSING BINDING PROPERTY WITH ORL1-RECEPTOR | 2002 |
|
RU2315750C2 |
SPIROCYCLIC DERIVATIVES OF CYCLOHEXANE WITH AFFINITY TO ORL1 RECEPTOR | 2004 |
|
RU2383544C2 |
SUBSTITUTED 4-AMINOCYCLOHEXANE DERIVATIVES | 2009 |
|
RU2503660C2 |
SUBSTITUTED DERIVATIVES OF 4-AMINOCYCLOHEXANE | 2009 |
|
RU2525236C2 |
SUBSTITUTED DERIVATIVES OF 4-AMINOCYCLOHEXANE | 2009 |
|
RU2532545C2 |
SUBSTITUTED DERIVATIVES OF C-CYCLOHEXYLMETHYLAMINE, MEDICINAL AGENT AND USING | 2001 |
|
RU2295515C2 |
SPIROCYCLIC CYCLOHEXANE DERIVATIVES | 2008 |
|
RU2484092C2 |
Authors
Dates
2008-04-10—Published
2002-05-08—Filed